Literature DB >> 31033046

Flushing of peripheral intravenous catheters: A pilot, factorial, randomised controlled trial of high versus low frequency and volume in paediatrics.

Tricia M Kleidon1,2, Samantha Keogh2,3, Julie Flynn2,4,5, Jessica Schults1,2,5, Gabor Mihala2,6, Claire M Rickard2,4,5.   

Abstract

AIM: To test the feasibility of an efficacy trial comparing different flushing frequencies and volumes to reduce peripheral intravenous cannula (PIVC) failure in paediatric inpatients.
METHODS: Pilot, 2 × 2 factorial, randomised controlled trial comparing PIVC flushing techniques in intervention pairs: (i) low volume (3 mL) versus high volume (10 mL); and (ii) low frequency (24 hourly) versus high frequency (6 hourly). Patients were excluded if: fluids were restricted, weight < 5 kg, PIVC already in situ for >24 h or continuous infusion. The primary end-point was feasibility (eligibility, recruitment, retention, protocol adherence, missing data and sample size estimates) of a large trial. Secondary end-points were PIVC failure (composite and individual), bloodstream infection and mortality.
RESULTS: A total of 919 children were screened from April to November 2015, with 55 enrolled. Screening feasibility criteria were not met, mainly due to continuous infusions and PIVCs in situ >24 h or planned for imminent removal. However, 80% of eligible participants consented, 2% withdrew, protocol adherence was 100%, and there was no missing primary end-point data. PIVC failure was significantly higher (hazard ratio = 2.90, 95% confidence interval: 1.11-7.54) in the 3 mL compared to the 10 mL group. There was no difference in failure between frequency groups (hazard ratio = 0.91, 95% confidence interval: 0.36-2.33). There was no interaction effect (P = 0.22).
CONCLUSION: Trial feasibility proved challenging due to eligibility criteria, which could be improved with additional recruiting staff. Firm conclusions cannot be made based on this small sample, but flush volume may impact PIVC failure.
© 2019 Paediatrics and Child Health Division (The Royal Australasian College of Physicians).

Entities:  

Keywords:  adverse effects; catheterisation; paediatric; peripheral venous device; randomised controlled trial

Mesh:

Year:  2019        PMID: 31033046     DOI: 10.1111/jpc.14482

Source DB:  PubMed          Journal:  J Paediatr Child Health        ISSN: 1034-4810            Impact factor:   1.954


  2 in total

1.  Risk factors for peripheral intravascular catheter-related phlebitis in critically ill patients: analysis of 3429 catheters from 23 Japanese intensive care units.

Authors:  Hideto Yasuda; Claire M Rickard; Nicole Marsh; Ryohei Yamamoto; Yuki Kotani; Yuki Kishihara; Natsuki Kondo; Kosuke Sekine; Nobuaki Shime; Keita Morikane; Takayuki Abe
Journal:  Ann Intensive Care       Date:  2022-04-08       Impact factor: 10.318

2.  The Efficacy, Safety, and Convenience of a New Device for Flushing Intravenous Catheters (Baro Flush™): A Prospective Study.

Authors:  Youn I Choi; Jae Hee Cho; Jun-Won Chung; Kyoung Oh Kim; Kwang An Kwon; Han Yong Chun; Dong Kyun Park; Yoon Jae Kim
Journal:  Medicina (Kaunas)       Date:  2020-08-05       Impact factor: 2.430

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.